XOLAIR
75MG INJ PSO LQF 1+1X2ML AMP
SÚKL code | 0025446 |
---|---|
Name of the product | XOLAIR |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | XOLAIR |
Supplement | 75MG INJ PSO LQF 1+1X2ML AMP |
Strenght | 75MG |
Pharmaceutical form | Powder and solvent for solution for injection |
Package | 1+1X2ML AMP |
Route | Subcutaneous use |
Wrap type | Vial |
Legal status | na lékařský předpis |
Active substance | OMALIZUMAB (OMALIZUMABUM) |
ATC group | R03DX05 |
ATC group name | OMALIZUMAB |
Marketing authorisation information
Registration Number | EU/1/05/319/001 |
---|---|
Type of MA | centralised without orphans |
MA status | R - active MA/authorised medicinal product |
MA Holder | Novartis Europharm Limited, Dublin |
MA Holder country | IRSKO |